Christine Stanislaw MS/CGC
- Department of Human Genetics
Assistant Professor
-
Winship Cancer Institute at Tufts House
2004 Ridgewood Drive, Suite 210
Atlanta, GA 30322
Overview
Christine Stanislaw is the Director of Genetic Counseling for the Winship Cancer Institute. Ms. Stanislaws research interests include increasing awareness of and access to cancer genetic services, particularly to underserved populations. She also has a research collaboration in familial amyotrophic lateral sclerosis (ALS) with investigators at the University of Miami.
She has over 15 years of experience as a clinical rotation supervisor, having worked with approximately 40 students from four different training programs. She successfully obtained funding to develop genetic counseling and testing for under-served populations in Atlanta and is involved in clinical research on familial ALS. Ms. Stanislaw is a cancer clinical supervisor, and primary course instructor for Genetics of Common Diseases (HGC 760).
Academic Appointment
- Assistant Professor, Department of Human Genetics, Emory University School of Medicine
Education
Degrees
- M.S. from University of South Carolina
- BS from Wake Forest University
Research
Focus
-
Clinical Cancer Genetics and Service Delivery Models
Primary research interest is the provision of clinical cancer genetic services to underserved and low literacy populations including increasing awareness of services, access to care and community and provider education. Secondary focus is the exploration of alternative service delivery models for genetic counseling to increase access to care.
Publications
-
Hereditary Colorectal Cancer Diagnosis by Next-Generation Sequencing.
Curr Protoc Volume: 3 Page(s): e941
12/01/2023 Authors: Wen T; Ehivet F; Stanislaw C; Mao R; Hegde M -
Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study.
Public Health Genomics Page(s): 1 - 14
08/09/2022 Authors: Rose E; Hardy MW; Gates R; Stanislaw C; Meisel J; Grinzaid KA -
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Brain Volume: 145 Page(s): 27 - 44
03/29/2022 Authors: Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S -
Impact of Implementing B-RSTTM to Screen for Hereditary Breast and Ovarian Cancer on Risk Perception and Genetic Counseling Uptake Among Women in an Academic Safety Net Hospital.
Clin Breast Cancer Volume: 19 Page(s): e547 - e555
08/01/2019 Authors: Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C -
Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST).
Genet Med Volume: 21 Page(s): 181 - 184
01/01/2019 Authors: Bellcross C; Hermstad A; Tallo C; Stanislaw C -
Identification and referral of women at risk for BRCA mutations.
Volume: 36
05/20/2018 Authors: Bellcross C; Hermstad A; Tallo CL; Leonard C; Pencea I; Stanislaw CL; Kohlmann W -
Prevention and Screening in Hereditary Breast and Ovarian Cancer.
Oncology (Williston Park) Volume: 30 Page(s): 896 - 904
10/15/2016 Authors: Zeichner SB; Stanislaw C; Meisel JL -
Presymptomatic ALS genetic counseling and testing: Experience and recommendations.
Neurology Volume: 86 Page(s): 2295 - 2302
06/14/2016 Authors: Benatar M; Stanislaw C; Reyes E; Hussain S; Cooley A; Fernandez MC; Dauphin DD; Michon S-C; Andersen PM; Wuu J -
Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.
Cancer Biol Med Volume: 13 Page(s): 55 - 67
03/01/2016 Authors: Stanislaw C; Xue Y; Wilcox WR -
Adverse events in cancer genetic testing: the third case series.
Cancer J Volume: 20 Page(s): 246 - 253
01/01/2014 Authors: Bonadies DC; Brierley KL; Barnett RE; Baxter MD; Donenberg T; Ducaine WL; Ernst ME; Homer J; Judkins M; Lovick NM